Wealthfront’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | $2.84M | Buy |
8,036
+728
| +10% | +$257K | 0.03% | 95 |
|
|
2018
Q2 | $2.12M | Buy |
7,308
+2,403
| +49% | +$697K | 0.02% | 118 |
|
|
2018
Q1 | $1.34M | Sell |
4,905
-2,989
| -38% | -$818K | 0.01% | 192 |
|
|
2017
Q4 | $2.52M | Buy |
7,894
+2,011
| +34% | +$641K | 0.03% | 95 |
|
|
2017
Q3 | $1.84M | Buy |
5,883
+2,526
| +75% | +$791K | 0.02% | 120 |
|
|
2017
Q2 | $911K | Buy |
3,357
+220
| +7% | +$59.7K | 0.01% | 164 |
|
|
2017
Q1 | $858K | Sell |
3,137
-71
| -2% | -$19.4K | 0.02% | 144 |
|
|
2016
Q4 | $910K | Sell |
3,208
-1,144
| -26% | -$325K | 0.02% | 124 |
|
|
2016
Q3 | $1.36M | Buy |
4,352
+3,482
| +400% | +$1.09M | 0.03% | 82 |
|
|
2016
Q2 | $210K | Sell |
870
-1,833
| -68% | -$442K | 0.01% | 335 |
|
|
2016
Q1 | $704K | Sell |
2,703
-215
| -7% | -$56K | 0.02% | 109 |
|
|
2015
Q4 | $894K | Sell |
2,918
-203
| -7% | -$62.2K | 0.03% | 91 |
|
|
2015
Q3 | $911K | Buy |
3,121
+1,382
| +79% | +$403K | 0.04% | 86 |
|
|
2015
Q2 | $702K | Buy |
1,739
+173
| +11% | +$69.8K | 0.03% | 79 |
|
|
2015
Q1 | $661K | Buy |
1,566
+581
| +59% | +$245K | 0.03% | 64 |
|
|
2014
Q4 | $334K | Buy |
985
+65
| +7% | +$22K | 0.02% | 107 |
|
|
2014
Q3 | $304K | Buy |
920
+201
| +28% | +$66.4K | 0.02% | 93 |
|
|
2014
Q2 | $238K | Buy |
719
+127
| +21% | +$42K | 0.02% | 89 |
|
|
2014
Q1 | $183K | Buy |
+592
| New | +$183K | 0.02% | 62 |
|